Mark Shlomchik was elected as a Distinguished Fellow of the AAI

UPMC Endowed and Distinguished Professor Mark Shlomchik was elected as a 2024 Distinguished Fellow of the American Association of Immunologists (AAI). It is among the highest honors bestowed by the AAI.

The Distinguished Fellowship recognizes active, long-term members who have demonstrated excellence in research accomplishment in the field of immunology, exceptional leadership to the immunology community in academia at a national or international level and notable distinction as an educator.

Shlomchik — who also co-founded and served as chief scientific officer at Bluesphere Bio, a translational sciences company developing therapies that harness the immune response of patients to cure cancer — chaired the Department of Immunology in Pitt’s School of Medicine from 2013-22. He has made several fundamental contributions to understanding autoimmune diseases and immune responses, most recently in a Nature Immunology study that explains the developmental origins of memory B cells, which underly how vaccines and post-infection immunity are protective.